Emily Xu is a seasoned policy advisor currently serving on the Zoonoses and Horizontal Policy Team at the Public Health Agency of Canada since October 2021. With a strong background in health research policy, Emily has been a policy analyst at the Canadian Institutes of Health Research since April 2016, where responsibilities include developing funding policies and supporting research knowledge translation and ethics. Previously, Emily worked as a laboratory technician at Health Canada from May 2014 to April 2016, focusing on potency testing of viral vaccines, and as a researcher at the Children's Hospital of Eastern Ontario from January 2013 to January 2014, conducting gene screening and molecular biology studies. Academic qualifications include a Master of Science in Physiology from the University of Toronto and a Bachelor of Science in Biology from the University of Prince Edward Island.
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
The Canadian Institutes of Health Research (CIHR) is the Government of Canada's health research investment agency. CIHR's mission is to create new scientific knowledge and to enable its translation into improved health, more effective health services and products, and a strengthened health care system for Canadians. Composed of 13 Institutes, CIHR provides leadership and support to more than 13,700 health researchers and trainees across Canada. Terms and Conditions: http://www.cihr-irsc.gc.ca/e/14202.html